Literature DB >> 18569840

Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.

Sameer Bakhshi1, K S Padmanjali, L S Arya.   

Abstract

A retrospective analysis was performed on febrile neutropenic episodes in patients with acute lymphoblastic leukemia (ALL) from 1992 to 2002. There were 222 febrile neutropenic episodes in 266 ALL patients with documented ANC < 500/mm(3). Of the 222 episodes, 98 (44%) had documented focus of infection; the rest were fever without focus. There were 274 different sites of infection in the 98 episodes of documented focus of infection; pulmonary infections were the commonest site of infection (27.3%) followed by HEENT (22.9%). Of 69 bacterial isolates, gram-negative bacteria (n = 46, 67%) were twice as common as gram-positive bacteria (n = 23, 33%). Most common site of isolation for gram-negative bacteria was blood (50%) followed by urine (32.6%). Blood (78.3%) was predominant site of isolation of gram-positive bacteria followed by HEENT (8.7%). Escherichia coli (45.7%) was the commonest gram-negative isolate, while Staphylococcus aureus (39%) was the commonest gram-positive bacterial isolate. There were a total of 22 fungal isolates, the majority from urine (n = 12) and HEENT (n = 9). Of the 22 fungal isolates, 19 were detected in induction phase of chemotherapy. A total of 95/222 (42.8%) febrile neutropenic episodes improved with first-line antibiotic therapy, while modification was required in 127 episodes (57.2%). Antifungal therapy was used in 86 episodes (38.7%). There were a total of 13 deaths, 6 each during induction and intensification/consolidation phases, while 1 died during maintenance phase. Of the 13 deaths, 10 had pneumonia, 8 had bacteremia, and 7 had fungal infection. The current study stresses the importance of frequent reviewing of type, frequency, severity, and outcome of infection complications over the years to detect changing epidemiological patterns. The majority of fungal infections were detected during induction chemotherapy, which highlights the need to consider this type of infection in the evaluation of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18569840     DOI: 10.1080/08880010802106564

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  16 in total

1.  Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.

Authors:  Jogender Kumar; Amitabh Singh; Rachna Seth; Immaculata Xess; Manisha Jana; Sushil Kumar Kabra
Journal:  Indian J Pediatr       Date:  2018-06-29       Impact factor: 1.967

2.  Can complications in febrile neutropenia be predicted? Report from a developing country.

Authors:  Sapna Oberoi; Anirban Das; Amita Trehan; Pallab Ray; Deepak Bansal
Journal:  Support Care Cancer       Date:  2017-06-11       Impact factor: 3.603

3.  Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India.

Authors:  Indranil Ghosh; Vinod Raina; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Sanjay Thulkar; Arti Kapil
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

4.  Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience.

Authors:  D Averbuch; C Avaky; M Harit; P Stepensky; I Fried; T Ben-Ami; V Temper; Y Peled; H Troen; R Masarwa; W Abu Ahmad; M Weintraub; S Revel-Vilk; D Engelhard
Journal:  Infection       Date:  2017-02-15       Impact factor: 3.553

5.  Clinical Features and Risk Factors of Severe Pneumonia in Children With Acute Lymphoblastic Leukemia.

Authors:  Chun-Yan Liu; Cheng Li
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.569

6.  Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.

Authors:  Meenakshi Bothra; Rachna Seth; Arti Kapil; S N Dwivedi; Shinjini Bhatnagar; Immaculata Xess
Journal:  Indian J Pediatr       Date:  2012-12-21       Impact factor: 1.967

7.  Symptom to door interval in febrile neutropenia: perspective in India.

Authors:  Sapna Oberoi; Amita Trehan; R K Marwaha; Deepak Bansal
Journal:  Support Care Cancer       Date:  2012-12-15       Impact factor: 3.603

8.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

9.  Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients.

Authors:  Yeter Düzenli Kar; Zeynep Canan Özdemir; Özcan Bör
Journal:  Turk Pediatri Ars       Date:  2017-12-01

10.  Febrile neutropenia: outline of management.

Authors:  Sapna Oberoi; Renu Suthar; Deepak Bansal; R K Marwaha
Journal:  Indian J Pediatr       Date:  2012-11-22       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.